A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Abramson Cancer Center at Penn Medicine
Kasr El Aini Hospital
M.D. Anderson Cancer Center
Mayo Clinic
Soligenix
4SC AG
University of Pittsburgh
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Soligenix
Genmab
Genmab
Atara Biotherapeutics
Centre for Human Drug Research, Netherlands
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Soligenix
4SC AG
Rochester Skin Lymphoma Medical Group, PLLC
Northwestern University
Novartis
Roswell Park Cancer Institute
AbbVie
Fred Hutchinson Cancer Center
Moleculin Biotech, Inc.
Takeda
Northwestern University
miRagen Therapeutics, Inc.
National Cancer Institute (NCI)
Mayo Clinic
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Mayo Clinic
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center